In cancer (Sun et al. 2020) and diabetes (Yin et al. 2020), AURKA has been demonstrated to function in glucose metabolism, suggesting that AURKA might promote the high glucose metabolism in microvascular endothelial cells to relieve VEGFA resistance. Here, AURKA is linked to diabetes mellitus.